These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33863792)

  • 21. An historical approach to the genetic distribution of KIR and HLA ligands in Eastern Sicilians compared to modern descendants of their invaders.
    Capittini C; Messina F; Puglisi F; Azzaro M; Toscano S; De Silvestri A; Tinelli C; Sortino G
    Hum Immunol; 2018 Jan; 79(1):5-12. PubMed ID: 29078989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
    Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
    Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis.
    Margolis DJ; Mitra N; Hoffstad OJ; Berna R; Kim BS; Chopra A; Phillips EJ
    Sci Rep; 2023 Jan; 13(1):1730. PubMed ID: 36720995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association between KIR and HLA-C type and susceptibility to idiopathic bronchiectasis.
    McDonnell MJ; Anwar GA; Rutherford RM; De Soyza A; Worthy S; Corris PA; Lordan JL; Bourke S; Afolabi G; Ward C; Middleton P; Middleton D
    Respir Med; 2014 Aug; 108(8):1127-33. PubMed ID: 24986480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.
    Bossi G; Mannarino S; Pietrogrande MC; Salice P; Dellepiane RM; Cremaschi AL; Corana G; Tozzo A; Capittini C; De Silvestri A; Tinelli C; Pasi A; Martinetti M
    Genes Immun; 2015 Oct; 16(7):481-7. PubMed ID: 26335810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis.
    Margolis DJ; Mitra N; Kim B; Gupta J; Hoffstad OJ; Papadopoulos M; Wubbenhorst B; Nathanson KL; Duke JL; Monos DS; Kamoun M
    Hum Immunol; 2015 Aug; 76(8):571-7. PubMed ID: 26307177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients.
    Zhao XY; Chang YJ; Xu LP; Zhang XH; Liu KY; Li D; Huang XJ
    Br J Cancer; 2014 Sep; 111(6):1080-8. PubMed ID: 25077441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity.
    Yun G; Tolar J; Yerich AK; Marsh SG; Robinson J; Noreen H; Blazar BR; Miller JS
    Clin Immunol; 2007 Jun; 123(3):272-80. PubMed ID: 17446137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KIR genes and HLA class I ligands in Gaucher disease.
    Vairo F; Portela P; Salim PH; Jobim M; Netto C; Dorneles A; Mittlestadt S; Jobim LF; Schwartz IV
    Gene; 2013 Mar; 516(1):53-7. PubMed ID: 23266622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group.
    Jobim MR; Jobim M; Salim PH; Portela P; Jobim LF; Leistner-Segal S; Bittelbrunn AC; Menke CH; Biazús JV; Roesler R; Schwartsmann G
    Hum Immunol; 2013 Sep; 74(9):1130-3. PubMed ID: 23792055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
    Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
    Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
    Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
    Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Variants in
    Shen C; Ge Z; Dong C; Wang C; Shao J; Cai W; Huang P; Fan H; Li J; Zhang Y; Yue M
    Front Immunol; 2021; 12():632353. PubMed ID: 34220799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIR and HLA-C Genetic Polymorphisms Influence Plasma IP-10 Concentration in Antiretroviral Therapy-Naive HIV-Infected Adult Zimbabweans.
    Mhandire K; Zijenah LS; Tshabalala M; Yindom LM; Mlambo T; Mhandire DZ; Musarurwa C; Duri K; Rowland-Jones S; Dandara C; Stray-Pedersen B
    OMICS; 2019 Feb; 23(2):111-118. PubMed ID: 30614763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
    Vejbaesya S; Nonnoi Y; Tanwandee T; Srinak D
    J Med Virol; 2011 Oct; 83(10):1733-7. PubMed ID: 21755501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.
    Di Bona D; Aiello A; Colomba C; Bilancia M; Accardi G; Rubino R; Giannitrapani L; Tuttolomondo A; Cascio A; Caiaffa MF; Rizzo S; Di Lorenzo G; Candore G; Duro G; Macchia L; Montalto G; Caruso C;
    J Viral Hepat; 2017 Sep; 24(9):768-775. PubMed ID: 28211154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.